STK11 and ovarian carcinoma: We observed a dramatic reduction in cell viability in ovarian cancer spheroids when loss of LKB1 was combined with carboplatin treatment, whereas this effect was not seen is spheroids with PRKAA1 knockdown, or in adherent cells under all treatment conditions (Figure 5C).